Evaluate the Safety and Clinical Activity of HH2853
Evaluate the Safety and Clinical Activity of HH2853
Recruiting · NCT04390737 · Registry updated 2026-01-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluate the Safety and Clinical Activity of HH2853 | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, T-cell non-Hodgkin lymphoma, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mature T-cell and NK-cell non-Hodgkin lymphoma, neoplasm, sarcoma | Recruiting | Phase 1 / Phase 2 | 2026-01-30 | NCT04390737 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Haihe Biopharma Co., Ltd. | 5 |
25 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.